During the past decade, PAB Clinical Research conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 33 clinical trials were completed, i.e. on average, 103.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 21 clinical trials were completed. i.e. 190.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PAB Clinical Research" #1 sponsor was "Jazz Pharmaceuticals" with 5 trials, followed by "Cephalon" with 3 trials sponsored, "Eisai Inc." with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 3 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PAB Clinical Research" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator, "Dong-A ST Co., Ltd." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "PAB Clinical Research" are "Obstructive Sleep Apnea" (5 trials), "Idiopathic Hypersomnia" (3 trials), "Narcolepsy" (3 trials), "Overactive Bladder" (3 trials) and "Covid19" (2 trials). Many other conditions were trialed in "PAB Clinical Research" in a lesser frequency.

Most popular intervention types in "PAB Clinical Research" are "Drug" (57 trials), "Other" (6 trials), "Biological" (4 trials), "Behavioral" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Daridorexant 25 mg" (3 trials), "Daridorexant 50 mg" (3 trials), "JZP-110" (3 trials) and "AD109" (2 trials). Other intervention names were less common.

The vast majority of trials in "PAB Clinical Research" are 57 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "PAB Clinical Research". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in PAB Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in PAB Clinical Research, 2 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".